Impact of stoichiometry representation on simulation of genotype-phenotype relationships in metabolic networks. by Brochado, Ana Rita et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Impact of stoichiometry representation on simulation of genotype-phenotype
relationships in metabolic networks.
Brochado, Ana Rita; Andrejev, Sergej; Maranas, Costas D.; Patil, Kiran R.
Published in:
P L o S Computational Biology (Online)
Link to article, DOI:
10.1371/journal.pcbi.1002758
Publication date:
2012
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Brochado, A. R., Andrejev, S., Maranas, C. D., & Patil, K. R. (2012). Impact of stoichiometry representation on
simulation of genotype-phenotype relationships in metabolic networks. P L o S Computational Biology (Online),
8(11), e1002758. DOI: 10.1371/journal.pcbi.1002758
Impact of Stoichiometry Representation on Simulation of
Genotype-Phenotype Relationships in Metabolic
Networks
Ana Rita Brochado1,2, Sergej Andrejev1, Costas D. Maranas3, Kiran R. Patil1*
1 Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany, 2Center for Microbial Biotechnology, Department of Systems
Biology, Technical University of Denmark, Lyngby, Denmark, 3Department of Chemical Engineering, Pennsylvania State University, University Park, Pennsylvania, United
States of America
Abstract
Genome-scale metabolic networks provide a comprehensive structural framework for modeling genotype-phenotype
relationships through flux simulations. The solution space for the metabolic flux state of the cell is typically very large and
optimization-based approaches are often necessary for predicting the active metabolic state under specific environmental
conditions. The objective function to be used in such optimization algorithms is directly linked with the biological
hypothesis underlying the model and therefore it is one of the most relevant parameters for successful modeling. Although
linear combination of selected fluxes is widely used for formulating metabolic objective functions, we show that the
resulting optimization problem is sensitive towards stoichiometry representation of the metabolic network. This undesirable
sensitivity leads to different simulation results when using numerically different but biochemically equivalent stoichiometry
representations and thereby makes biological interpretation intrinsically subjective and ambiguous. We hereby propose a
new method, Minimization of Metabolites Balance (MiMBl), which decouples the artifacts of stoichiometry representation
from the formulation of the desired objective functions, by casting objective functions using metabolite turnovers rather
than fluxes. By simulating perturbed metabolic networks, we demonstrate that the use of stoichiometry representation
independent algorithms is fundamental for unambiguously linking modeling results with biological interpretation. For
example, MiMBl allowed us to expand the scope of metabolic modeling in elucidating the mechanistic basis of several
genetic interactions in Saccharomyces cerevisiae.
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Introduction
The fundamental role of metabolism within a living cell has
become a focal point of study in many disciplines, such as cell
biology, physiology, medicine and synthetic biology. The assembly
of all reactions and metabolites into a genome-scale metabolic
network provides a comprehensive structural framework for
integrative data analysis [1,2], as well as for quantitative modeling
of cellular metabolism [3–6]. As the solution space for the
metabolic flux state of the cell is typically very large, constraint
based optimization approaches are often applied for simulating
metabolic fluxes. In essence, these approaches search for an
optimal flux distribution that maximizes or minimizes an
appropriate biological objective function while satisfying the mass
balance and metabolite exchange constraints. Among these, Flux
Balance Analysis [7] is a widely used simulation tool that utilizes a
linear programming formulation for maximization of growth
(synthesis of biomass constituents) as biological objective function.
FBA has been applied with various degrees of success, albeit
mostly for ‘‘wild-type’’ or unperturbed metabolic networks [8,9].
In addition to FBA, various other objective functions are
frequently used, including minimization of overall intracellular
flux and maximization of ATP yield, among others. An overview
of various commonly used objective functions and their evaluation
against experimental data for Escherichia coli can be found in
Schuetz et al. [10]. In case of genetically or environmentally
perturbed networks, Minimization of Metabolic Adjustment
algorithm - MoMA [11] - has been reported to better represent
the biological observations [11–14]. The hypothesis underlying
MoMA is that fluxes in a perturbed cell (e.g. a mutant) will be
redistributed so as to be as similar as possible to the wild-type.
The biological principles exemplified by simulation tools for
both wild-type and perturbed networks are undeniably fascinating,
which is confirmed by their numerous applications – including
prediction of genetic interactions [2,15,16], metabolic engineering
[13,14,17], microbial community modeling [18,19] and search for
evolutionary constraints in relation to different objective functions
[20]. Several of the objective functions commonly used in these
and other applications rely on the use of linear combination of
fluxes, e.g., MoMA or minimization of overall intracellular flux
(Table 1). We found that the mathematical formulation of this
class of problems (i.e. where linear combination of fluxes is part of
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the objective function) is sensitive to the representation of the
reaction stoichiometry, with results strongly dependent on the
adopted scaling of the stoichiometric coefficients. Such dependen-
cy confounds the biological interpretation of simulation results, as
biochemically equivalent alternative representations of the same
network can lead to contradictory predictions upon a given genetic
or environmental perturbation. For example, the status of a given
gene may change from non-essential to essential while using
biochemically equivalent representations of the stoichiometry of
the metabolic network (Table S1). As the stoichiometric
representation of any reaction is subjective (often scaled to have
coefficient of 1 for one of the reactants/products) and a typical
genome-scale modeling problem involves hundreds of reactions,
there are infinitely many biochemically equivalent ways to
represent a given metabolic network. Any simulation algorithm
should therefore be independent of the stoichiometry representa-
tion.
We motivate the need for rethinking the problem formulation
for metabolic modeling by illustrating how the current methods
lead to incoherent biological predictions when alternatively
representing the reaction stoichiometry. Tackling a proper
problem formulation, we propose a new methodology for
metabolic modeling – Minimization of Metabolites Balance
(MiMBl), which accounts for reaction stoichiometry in the
objective function by mapping the flux space into the metabolite
turnover space. As intended, MiMBl shows robust predictions
independently of the stoichiometry representation. We demon-
strate the biological relevance of the new formulation with
increased power for predicting genetic interactions in the
metabolic network of S. cerevisiae. In a recent study reporting a
large genetic interactions dataset covering the S. cerevisiae metabolic
network [2], FBA was found to have limited capability for
predicting the experimentally observed interactions, partially due
to the lack of regulatory information. Within this study we
successfully challenged MiMBl to accomplish the task of extending
the range of genetic interactions that can be predicted. By
combining the results from MiMBl and FBA, we probe the
operating mechanisms underlying genetic interactions within
metabolic networks.
Results/Discussion
Several of the biological objective functions widely used in
metabolic modeling are currently formulated as linear (or
quadratic) combination of fluxes. Minimization of sum of
intracellular fluxes and minimization of metabolic adjustment
belong to this class and are herein used as case studies of biological
principles that can be robustly formulated by using MiMBl. Two
different genome-scale reconstructions of the S. cerevisiae metabolic
network are used, viz. iFF708 [21] and iAZ900 [22], as the choice
of the appropriate metabolic reconstruction depends on the
biological question to be addressed (Methods).
Stoichiometry representation and minimization of sum of
fluxes
Minimization of the sum of intracellular flux is a routinely used
objective function for estimating intracellular fluxes [10,20,23,24].
By using the iFF708 S. cerevisiae genome-scale metabolic recon-
struction [21] together with experimentally determined exchange
rate constraints (Text S1), we illustrate how the use of this
objective function leads to inconsistent predictions when using
numerically different, but biochemically equivalent, reaction
stoichiometry. Linear scaling of all stoichiometric coefficients of
a given reaction (e.g. multiplication by a scalar h, Methods)
preserves the stoichiometry and must not affect the simulation
outcome for a correct problem formulation. However, in this case,
scaling of a single reaction (RPI1) results in diverting the carbon
flow from glycolysis to pentose phosphate pathway, which is one of
the most important metabolic branch points (Fig. 1). This
deviation was verified not to be consequence of alternative optima
of the same mathematical solution (Fig. S2), thus representing
different biological solutions.
In order to provide insight into the nature of the problem
leading to the susceptibility of the solution towards alternative
representation of the stoichiometric matrix, we use a toy-model
depicted in Fig. 2a. As a case study, minimization of metabolic
adjustment was chosen as biological principle and formulated as
minimization of Manhattan distance (a commonly used formula-
tion of MoMA, termed lMoMA [25]). Fig. 2 also illustrates the
representation dependency of the Euclidean distance formulation
of MoMA (quadratic MoMA, as originally proposed in [11]). In
order to provide an intuitive insight, the following discussion is
centered on lMoMA. Similar explanation holds true in quadratic
space in the case of quadratic MoMA. In the wild-type toy-model,
flux goes from A to D via R5. The goal is to predict flux
distribution in the mutant lacking R5. The biological principle of
minimization of metabolic adjustment dictates rewiring of the flux
through R6. However, lMoMA found contradictory optimal
solutions, i.e. solutions that re-route the flux via R2–R3–R4 or
R6, depending on the stoichiometric representation of R6
(Fig. 2b). Insight into the cause of this behavior can be gained
by analyzing the optimal objective function values, i.e. distances, as
function of hR6 (Fig. 2d). Smaller hR6 implies higher numerical
value of the flux through R6, hence higher contribution of R6 to
the distance. Consequently, after a certain value of hR6, the
activation of the longer R2–R3–R4 pathway more than compen-
sates the use of R6. The two solutions are not alternative optima,
as the objective function value neither remains constant nor
linearly scales with hR6. Such non-linear dependency of the
Author Summary
One of the challenging tasks in systems biology is to
quantitatively predict the metabolic behavior of the cell
under given genetic and environmental constraints. To this
end, genome-scale metabolic reconstructions and simula-
tion tools are indispensable. The choice of the objective
function to be used for simulating genome-scale meta-
bolic models is dependent on the biological context and
one of the most relevant parameters for successful
modeling. Formulation of the intended objective function
often requires the use of multiple fluxes, e.g. the sum of
fluxes through ATP-producing reactions. We demonstrate
that the existing tools confound biological interpretation
of the simulations due to undesired dependence on the
representation of stoichiometry and propose a new tool –
Minimization of Metabolites Balance (MiMBl). MiMBl allows
casting of the desired biological objective functions into
linear optimization models and gives consistent simulation
results when using numerically different but biochemically
equivalent stoichiometry representations. We demonstrate
relevance of MiMBl for addressing biological questions
through improved predictions of genetic interactions
within the yeast metabolic network. Genetic interactions
imply functional relationship between the genes and
therefore allow assessing different hypotheses for the
underlying biological principles. MiMBl explains several of
the genetic interactions as outcome of flux re-routing for
minimal metabolite turnover adjustments.
Objective Functions in Metabolic Modeling
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objective function value on the scalar hR6 violates the requirement of
a correct problem formulation. Indeed, we analytically demonstrate
that the optimality condition for the linear programming problem
after scaling is not guaranteed to be satisfied in the case of using sum
of fluxes as part of the objective function (Methods). Notably,
widely used FBA-like problems (max/minimization of a single flux)
are perfectly robust concerning the scaling of the stoichiometric
coefficients. As a single flux is used in the objective function, the
relative values of all the remaining fluxes (which depend on the
stoichiometry representation) does not influence the optimal
solution to be found (for a theoretical proof, see Text S2).
The mathematical caveat illustrated above means that the
contribution of the desired biological objective function towards
the obtained solution is inseparable from that of the artifacts of
stoichiometry representation. Importantly, in large metabolic
networks the effects of stoichiometric representation of reactions
are cumulative. As we herein show, this problem can be solved by
proper normalization of the objective function variables with respect
to stoichiometric representation of the reactions. To achieve such
normalization, we devised two approaches, normalized lMoMA
(normlMoMA) and Minimization of Metabolites Balance (MiMBl).
In normlMoMA, each variable in the objective function is
normalized by its value in the wild-type flux distribution. Albeit
being simple, this normalization method has three major draw-
backs: i) many reactions often have null fluxes in the wild-type, thus
posing a problem for normalization (Methods, Text S2 and Fig.
S3); ii) it requires a reference flux distribution to obtain the
normalization factors, making it inappropriate to formulate
objective functions such as minimization of overall intracellular
flux; and iii) the influence of each flux on the metabolic adjustment
would be exclusively due to its fold change, not taking into account
that reactions carrying higher fluxes could have a stronger impact
on the predicted flux distribution, as implied in the original concept
of minimization of metabolic adjustment.
Minimization of Metabolites Balance - MiMBl
To obtain a biological meaningful and mathematically robust
normalization, we propose Minimization of Metabolites Balance
(MiMBl) as a new method for metabolic modeling. The objective
function in MiMBl is formulated as a linear combination of
metabolite turnovers (tM). The turnover of a metabolite is the sum
of all fluxes producing (or consuming) it, multiplied by the
corresponding stoichiometric coefficients (Methods). The objec-
tive function for minimization of metabolic adjustment is
reformulated to include metabolite turnovers instead of fluxes
(Fig. 2c). Because the stoichiometric coefficients are taken into
account while calculating tM, MiMBl is robust to the linear scaling
of the stoichiometric matrix, analytical proof of which is presented
in the Methods section. In case of the toy-model (Fig. 2a, d), this
robustness is illustrated by the invariant nature of the objective
function as well as the flux distribution. Note that the flux through
R6 linearly scales with hR6, while the turnover of all metabolites is
conserved. The normalization implied in MiMBl formulation is
suitable for addressing a variety of biological questions involving
different objective functions, such as minimization of overall
intracellular flux (by using a null vector for wild-type flux
distribution) or maximization of ATP yield (by maximizing the
ATP turnover for a given substrate uptake rate), among others
(Table 1).
While mapping the flux space into the metabolite space for the
objective function formulation, as we do for MiMBl, it is possible
that, for a few cases, alternative flux distributions are found around
a given metabolite. We therefore introduce a second optimization
step that reinforces the proximity to the reference flux distribution.
This is achieved by using a normlMoMA routine where the
optimal objective function value found in the first MiMBl
optimization step is used as an additional constraint (Methods).
Nevertheless, highly connected metabolites ensure a degree of
network connectivity, which is sufficient for decreasing the number
of situations where alternative flux distributions around the same
metabolite are picked by MiMBl. Indeed, we did not find any case
in the simulations performed for this study where growth
prediction was altered in the second optimization step. An
example case where the second optimization step will be more
relevant is simulations involving export of metabolites, where the
choice of a particular transporter (as in the reference flux
Table 1. Formulation of different biological objective functions using MiMBl.
Biological objective
function
Previous objective
function Description
MiMBl objective
function Description
Minimization of metabolic
adjustment
min
P
i[N
DvWTi {vi D
[11]
Minimization of Manhattan
distance between the vectors
containing the reference and
mutant flux distributions
min
P
m[M
DtWTm {tm D Minimization of Manhattan
distance between the vectors
containing the reference and
mutant intracellular
metabolites turnover
Minimization of overall
intracellular flux
min
P
i[N
Dvi D
[23]
Minimization of the sum of all
intracellular fluxes
min
X
m[M
DtWTm {tm D
tWT~0
Minimization of the sum of
intracellular metabolites
turnover
Maximization or Minimization
of ATP yield max =min
P
vATP[N
vATP
vglucose
[35,36]
Max/Minimization of the
sum of all reactions
producing ATP
max =min
DtWTATP{tATP D
vglucose
tWT~0
Max/Minimization of ATP
turnover
Minimization of redox
potential min
P
vNADH[N
vNADH
vglucose
[35]
Minimization of the sum
of all reactions producing
NADH
min
DtWTNADH{tNADH D
vglucose
tWT~0
Minimization of NADH turnover
Maximization of biomass* max vGrowth
[7,37]
Maximization of
biomass flux
max tbiomass Maximization of biomass
turnover
*Note: Biomass production within metabolic models is typically represented as a single reaction accounting for all the biomass constitutes. Therefore, FBA and MiMBl
are equivalent for maximizing biomass.
doi:10.1371/journal.pcbi.1002758.t001
Objective Functions in Metabolic Modeling
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distribution) among several alternative options is desired. A more
thorough analysis of MiMBl alternative optima in a genome-scale
network is presented below (Fig. 3).
Lack of stoichiometric normalization confounds
biological interpretation
In order to estimate the extent to which the lack of
normalization of stoichiometric coefficients within the objective
function influences the biological interpretation of simulation
results, we used lMoMA for simulating gene knockouts in the S.
cerevisiae genome-scale metabolic model iFF708 [21]. In case of
single gene knockout, three genes were found to change their
status from non-essential to essential while using two biochemically
equivalent matrix representations (Table S1). For instance, the
mutant lacking YCR012W, coding for a 3-phosphoglycerate kinase
(pPGK1), was predicted to be viable when using the as-published
representation of the stoichiometric matrix S0 [21], and non-viable
while using the biochemically equivalent matrix S1 (Methods).
Based on such contradictory results, conclusions cannot be taken
on whether YCR012W is predicted to be essential or not. As the
number of deleted genes (or other network perturbations)
increases, cumulative phenotypic effects related to the functional
interactions between the genes are expected to take place and
examples as the one mentioned above become even more striking.
For triple gene knockouts, more than 200,000 triplets were found
such that their predicted phenotype switched from lethal to non-
lethal (or vice-versa) for the two biochemically equivalent matrix
representations (Table S1). From a biotechnological perspective,
predictions from genome-scale modeling have direct influence on
the choice of gene targets selected for metabolic engineering. By
using lMoMA, we identified metabolic engineering strategies (by
simulating all possible combinations of knockouts of up to three
genes, Text S1) for production of two different compounds in
yeast: succinate – a native product, and vanillin-glucoside – a
heterologous product. Not only a significant fraction of mutants
had divergent predictions for product yield when using two
biochemically equivalent stoichiometric matrices, but also several
highly ranked strategies in one case were low priority targets in the
other (Figs. S4, S5, S6, S7). Moreover, we also observed that the
number of predicted synthetic lethal pairs differed by more than
two-fold when using alternative stoichiometric matrix representa-
tions (Table S2). These inconsistencies have immediate implica-
tions on the consequent biological interpretation, as well as on the
Figure 1. Minimization of overall intracellular flux leads to
divergent predictions for flux distribution when using bio-
chemically equivalent stoichiometry representations. Shown are
predicted fluxes through key pathways within the S. cerevisiae central
carbon metabolism, using numerically different but biochemically
equivalent stoichiometric representation of reaction RPI1 (hRPI1,
Methods). hRPI1 is represented on the x-axis, while fold-change of
fluxes relatively to h=1 is represented on the y-axis. A representative
reaction from each of the pathways was selected to illustrate the flux re-
arrangement; FBA1 for glycolysis, ZWF1 for pentose phosphate
pathway, CIT1 for tricarboxilic acid cycle and NID1 for oxidative
phosphorylation. Note that h=1 is an arbitrary reference, as the
stoichiometric representation of any reaction is subjective, often scaled
to have coefficient of 1 for one of the reactants/products.
doi:10.1371/journal.pcbi.1002758.g001
Figure 2. MiMBl shows robust simulation results while using
alternative stoichiometry representations – illustration using a
toy-model. a) Toy-model: R1 to R7 and A to D represent reactions and
metabolites, respectively. In the wild-type, or reference, flux goes from
A to D via R5. R6 and R2–R3–R4 are two alternative pathways for flux re-
distribution after deletion of R5. b) Flux through reactions R2 (full
symbols) and R6 (open symbols) obtained after simulation of
minimization of metabolic adjustment with lMoMA (black), quadratic
MoMA (qMoMA, gray) and MiMBl (red) using numerically different but
biochemically equivalent representations of reaction R6 (given by
different scaling factor hR6, Methods). c) Formulation of objective
functions of minimization of metabolic adjustment for lMoMA, qMoMA
and MiMBl (Methods). d) Optimal objective function value (distance)
obtained for minimization of metabolic adjustment using lMoMA
(black), qMoMA (gray) and MiMBl (red) as function of hR6.
doi:10.1371/journal.pcbi.1002758.g002
Objective Functions in Metabolic Modeling
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experimental design, and can be successfully overcome by using
MiMBl (Fig. S4, Table S3).
Alternative optima and sensitivity towards reference flux
distribution
The above analysis proved the robustness of MiMBl towards
stoichiometric representation of metabolic reactions. However,
some degree of uncertainty in the simulation results might still
exist, as we shall show here, essentially arising from two main
sources (Fig. S8a): i) sensitivity of the results towards the initial
wild-type flux distribution used as input for minimizing the
metabolic distance; and ii) potential non-uniqueness of the linear
programming solution while simulating the mutant phenotype, i.e.
existence of alternative optima. The sensitivity analysis for MiMBl
towards both sources of uncertainty was performed using iAZ900
reconstruction of the yeast metabolic network, as the same
reconstruction is subsequently used to study genetic interactions
within the yeast metabolism. Both sources of variability also have
impact on lMoMA simulation results (Fig. S9).
Firstly, we analyzed the sensitivity towards the wild-type (or
reference) flux distribution used as input for minimization of
metabolic adjustment. Using an accurate reference flux distribu-
tion is crucial for obtaining biologically meaningful simulation
results. While some metabolite exchange rates are commonly
available as experimentally derived constraints for the wild-type,
they are usually not sufficient to uniquely estimate the corre-
sponding intracellular fluxes, e.g. by using FBA (Figs. S8a and
S1). It has been previously shown that the use of alternative
optima within the reference flux distribution obtained with FBA
can affect the prediction of growth upon gene deletions using
quadratic MoMA [11]. We herein performed a similar analysis by
using MiMBl. The growth of single gene deletion mutants was
simulated with MiMBl while using alternative optimal FBA flux
distributions as reference (Methods). Similarly to what was
previously observed for quadratic MoMA [11], cases were found
where the use of alternative FBA flux distributions, as input to
MiMBl, influences the growth prediction (Fig. 3). 70% of the
predictions of single gene deletion phenotypes were consistent
across all FBA-alternative-optima used, while the remaining 30%
showed dependence on the input reference flux distribution. Use
of additional experimentally determined constraints, for instance
as obtained with 13C flux analysis, will be useful for reducing the
uncertainty in the input flux distribution and thereby in obtaining
more robust predictions.
In order to assess the variability due to potential non-uniqueness
of the optimal solution obtained with MiMBl (Fig. S8a), we
performed a flux variability analysis [26]. Biologically, the
alternative optima correspond to the existence of alternative
pathways that result in equivalent mutant phenotypes with regards
to the required metabolic adjustment. For a fixed reference flux
distribution, we calculated the range of variability of intracellular
fluxes upon constraining the metabolic adjustment (i.e. sum of
metabolite turnover distance) to its optimal value (Methods). All
of the tested fluxes were observed to have very low or no variability
(vi
min/vi
max.0.99) across all single gene deletion phenotypes.
Utility of the second step of MiMBl was seen in case of the flux
through PGM1 upon deletion of YOR128C (Fig. S8b). Neverthe-
less, existence of a unique solution is problem dependent and it
should be verified whether the possibility of alternative optima
affects the prediction of fluxes of interest. Therefore, we performed
an exhaustive analysis of variability of growth prediction across all
single gene deletions, as well as all double gene deletions included
in the genetic interactions case study. Growth was uniquely
predicted in all these cases (Fig. S8c).
Predicting genetic interactions by using MiMBl
To what extent MiMBl contributes for increasing biological
understandings gained from the application of optimization-based
metabolic modeling? To address this question, we used one of the
most recent and comprehensive S. cerevisiae models, iAZ900 [22],
to run simulations for single and double gene knockouts and
challenged MiMBl to predict the epistasis scores of all significantly
interacting non-essential gene pairs reported by Szappanos et al.
[2]. Genetic interaction networks are valuable resources towards
deciphering the complex genotype-phenotype relationships. A
genetic interaction between two genes occurs when the phenotype
displayed by a double deletion mutant is different than the one
expected based on the phenotypes of the single mutants.
Accordingly, two genes can display positive, negative or no
interaction. In order to capture most of the biological information
contained in the experimental dataset, we used two different
objective functions, maximization of growth (FBA) and minimi-
zation of metabolic adjustment (MiMBl). FBA is expected to cover
situations where maximization of growth is the cellular objective,
while MiMBl will account for regulatory effects inherent to the
wild-type flux distribution, in the sense that the flux distribution in
the perturbed network is kept as close as possible to that of the
wild-type. This principle of proximity to the wild-type (or the
reference) should partially reflect principles of flux reorganization
in genetically perturbed networks. Although, both FBA and
MiMBl performed equally well concerning gene essentiality
predictions (,60% sensitivity, Text S1), the benefit of using
MiMBl as a biological objective function became apparent while
predicting genetic interactions. This implies that the biological
regulatory principle underlying MiMBl is manifested in yeast
Figure 3. Sensitivity of MiMBl towards the use of alternative
reference flux distributions. a) The histogram shows the distribu-
tion of variability in the predicted growth of single gene knockout
mutants while using 500 different FBA alternative optima as reference
flux distributions. b) Case study of YLR377C knockout simulations using
different reference flux distributions as input. The predicted growth
varies between 50–100% of that of the wild-type.
doi:10.1371/journal.pcbi.1002758.g003
Objective Functions in Metabolic Modeling
PLOS Computational Biology | www.ploscompbiol.org 5 November 2012 | Volume 8 | Issue 11 | e1002758
(under the investigated conditions) at larger network perturbations
or less drastic phenotypes than essentiality. When applied for
studying genetic interactions, FBA is a conservative method
compared to MiMBl, since the parameter used to define and
measure genetic interactions is also the objective of optimization,
i.e., growth. Within the metabolic network, the existence of several
optimal solutions theoretically satisfying maximum biomass
formation is often observed. In case of a single/double gene
deletion mutant where an alternative optimal pathway exists, FBA
will always find such an alternative solution, even though it may
not be biologically plausible due to regulatory constraints, and,
thereby may miss potential genetic interactions. On the other
hand, MiMBl will help in capturing more refined regulatory effects
where the loss of growth is a side effect of minimizing the flux
rerouting relative to the wild-type.
The subset of experimental genetic interactions involving non-
essential genes from the yeast metabolic model contains 2745
interactions (939 positive and 1806 negative) connecting 520 genes
(Text S1, Table S4). In order to assess the performance of the
different algorithms, we carried out a sensitivity versus precision
analysis. Precision was calculated as the fraction of experimentally
validated interactions among all predicted interactions, while the
sensitivity represents the fraction of the experimentally validated
interactions captured by the predictions (Text S1). A computa-
tional epistasis score cutoff (ecutoff) was used to call a particular
gene pair to be positively interacting (e.ecutoff), negatively
interacting (e,2ecutoff) or non-interacting (|e|,ecutoff) (Text
S1). The performance of all algorithms (MiMBl, FBA, lMoMA
and quadratic MoMA) is summarized as ROC (partial receiver
operating characteristic) curves for both, positive and negative
epistasis (Fig. 4 a, b and Fig. S10). The sensitivity and precision
of the FBA predictions obtained in this study are within the same
range as previously reported by Szappanos et al. [2]. MiMBl shows
less precision than FBA in case of both positive (,20% and
,30%, respectively) and negative interactions (,50% and ,60%,
respectively), but its sensitivity is considerably higher in both cases
(,9% vs ,4% for positive, Fig. 4a; ,5% vs ,3% for negative,
Fig. 4b), which reflects the conservative nature of FBA in
predicting genetic interactions. Notably, for the entire range of
genetic interaction cutoffs, MiMBl sensitivity and precision are
considerably higher than those of lMoMA (Fig. 4a, b). The same
trend was verified when the originally proposed quadratic MoMA
formulation was used (Fig. S10). As previously reported by
Szappanos and co-workers, lMoMA does not improve FBA
predictions. This observation further emphasizes that a proper
mathematical formulation of the biological principle (objective
function) has a major impact on the ability to interpret in vivo
observations.
We chose a strict interaction cutoff (|ecutoff| = 0.013) for further
analysis of the predicted interactions (Fig. S11). For this cutoff,
the correctly predicted genetic interactions map contains 142
interactions (73 positive and 69 negative) connecting 86 genes
(Fig. 4f). MiMBl not only captures all interactions, except one,
predicted by FBA, but also contributes with 48 additional
interactions (,34% of all accurate predictions). MiMBl predic-
tions thus span almost all of those from FBA (Fig. 4c), which we
attribute to the fact that many metabolites within the metabolic
model are directly contributing to the biomass formation.
Consequently, if the turnover of most metabolites is kept constant
upon gene deletions, the biomass turnover (growth) will also
remain constant. On the other hand, FBA is not able to capture
many genetic interactions found by MiMBl (Fig. 4c). These will
involve mutants where the loss of fitness upon gene deletion is
caused by the change from an in vivo well-tuned pathway to an
alternative pathway containing different metabolites or enzymes.
For many of such cases, there are alternative pathways that sustain
the same growth as the reference and FBA finds such solutions,
regardless of the magnitude of the turnover adjustment that is
required for the cell. Because of this feature, MiMBl is capable of
capturing a part of the regulatory constraints on the operation of
cellular metabolism, which lMoMA failed to capture (Fig. 4c).
The regulatory constraints imposed by MiMBl assume even
stronger relevance in the case of positive interactions, where
MiMBl exclusively accounts for almost 50% of all successfully
predicted interactions (Fig. 4f). In fact, FBA’s ability of predicting
positive interactions is limited, as the maximum predicted biomass
formation of a double deletion mutant would never be higher than
the highest among those predicted for the two single deletion
mutants. Thus, if a single deletion mutant has the maximum
predicted fitness of 1 (meaning that the fitness of the mutant is the
same as that of the wild-type), positive interactions involving the
deleted gene will be impossible to predict. As FBA is bound to find
the optimal solution that provides the highest growth, single
mutants with maximum fitness are much more often predicted
than the ones found by MiMBl, where minimal adjustment of the
metabolic network is preferred over maintaining maximum
growth. Indeed, MiMBl predicts decreased single mutant fitness
for twice more gene knockouts than FBA (,38.4 vs 18.1%).
Consequently, MiMBl also displayed an improved capacity to
predict both positive and negative epistasis involving the same
gene. More than 80% of the genes display this feature in vivo.
Interestingly, 30% of the genes involved in MiMBl predicted
epistasis interact both positively and negatively, while FBA predicts
that only 14% of the genes do so (Fig. 4f).
MiMBl predicts genetic interactions between distant
genes in the network
As metabolic networks are featured by several metabolites with
a high degree of connectivity, interactions occur between distant
pathways in the network. To assess MiMBl’s ability to predict such
pleiotropic effects, we calculated the network distance between
each pair of genes accurately predicted to interact (Text S1).
MiMBl captured interactions between genes that are significantly
more distant than in case of FBA (,40% more distant for negative
epistasis, p-value = 0.022; ,10% more distant for both positive
and negative epistasis, p-value = 0.089; Fig. 4d, e).
Predicting genetic interactions of isoenzymes
In a metabolic network reconstruction, a group of isoenzymes is
represented by a single reaction, which is associated with two or
more genes. Simulation-wise, such a reaction will be inactive only
when all of the corresponding isoenzyme-coding genes are deleted
and deletion of any single gene will not result in a loss of fitness.
Thus, in case of a reaction with two isoenzymes, when the deletion
of both isoenzyme-coding genes leads to decreased fitness in silico, a
negative interaction will be predicted. Our analysis captured
several of such cases, for example, the negative interactions
between SER3 and SER33, as well as between SAM1 and SAM2
(Fig. 4f). While this gene-deletion-centered approach allows
capturing interactions between isoenzyme-coding genes, it is not
suited for predicting interactions between two functionally
different genes where one (or both) of them have isoenzymes.
However, such interactions are often observed in vivo, since
isoenzymes do not always completely compensate each other’s
function due to differences in kinetic and/or regulatory charac-
teristics. Although these effects cannot be directly captured using
the currently available metabolic modeling tools, we suggest
evaluating the metabolic basis of genetic interactions between
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functionally different genes with isoenzymes by taking a reaction-
centered approach. For this purpose, flux through reactions
catalyzed by isoenzymes was constrained to zero when at least one
of the isoenzyme-coding genes was deleted. This way, five
additional genetic interactions involving isoenzymes were correctly
captured: a positive interaction between the isoenzyme group
TLK1 & TLK2 and the gene ARO1, as well as four negative
interactions involving the isoenzyme group ALD2-ALD6 and other
genes from the central carbon metabolism (Fig. 4f). These five
interactions are thus likely to result from flux rerouting caused by
the lack of compensation by the corresponding isoenzymes.
Combining MiMBl and FBA predictions for understanding
genetic interactions
Use of MiMBl not only allowed us to expand the range of genetic
interactions predicted by FBA, but also the combined use of these
two complementary algorithms enabled finding of relevant interac-
tions where only one or both simulation principles apply. For
example, the interaction between PGK2 and GDH2, exclusively
captured by MiMBl, is due to balancing of NADH and glutamate,
two of the most connected metabolites in the network. As there are
alternative pathways for fulfilling NADH and glutamate require-
ment (despite implying higher metabolic adjustments), FBA could
not capture this interaction. A similar effect is observed for the
negative interaction between isoenzymes SER3 and SER33. In the
absence of both genes, FBA predicts the needed supply of serine to
be totally fulfilled by rerouting the metabolic fluxes via the glyoxylate
shunt and threonine biosynthesis. On the other hand, MiMBl
predicts that the supply of serine will be shared between the two
alternative pathways, but the rescue cannot be complete, because the
corresponding metabolic adjustment cost overweighs the benefit of
increased growth. This prediction is in very good agreement with the
experimental verification that the double mutant growth is impaired
and can be restored by adding glycine to the medium, which is the
intermediate for serine synthesis via glyoxylate or threonine [27].
Overall, our results demonstrate that the use of optimization-
based algorithms that are stoichiometry representation indepen-
dent is fundamental for unambiguously linking modeling results
with biological interpretation. To this end, we report a new
method for formulating objective functions for metabolic modeling
– MiMBl. As a biological case study, we used MiMBl to gain
insights into the flux rewiring underlying genetic interactions
within the yeast metabolic network. The analysis showed that the
combined use of different objective functions is of primary
importance in order to achieve a more complete understanding
of the operating principles behind complex biological phenomena
such as genetic interactions. Indeed, the number of accurately
predicted genetic interactions was almost doubled owing to the use
of MiMBl, highlighting the impact of metabolic adjustment
constraints on the operation of perturbed metabolic networks. In
conclusion, MiMBl provides a framework for consistent mathe-
matical formulation of biological objective functions and thereby
facilitates unraveling of the genotype-phenotype relations in
metabolic networks.
Methods
Yeast genome-scale metabolic reconstructions
The susceptibility of the modeling results towards the stoichi-
ometry representation is inherent to the formulation of the
objective function; and it is independent of the choice of metabolic
network reconstruction. Two reconstructions were therefore
selected in this study based on their suitability for addressing the
biological principle in question. iFF708 [21] was the reconstruc-
tion of choice for illustrating the prediction of internal flux
distribution and metabolic engineering targets, as i) this recon-
struction has been successfully used for model guided metabolic
engineering [13,14] and, ii) when constrained with experimentally
measured substrate and product exchange rates [28] (Text S1),
iFF708 showed less flux variability at physiologically important
flux nodes as opposed to more recent reconstruction iAZ900 [22]
(Fig. S1). On the other hand, for studying large-scale genetic
interactions in yeast, we used iAZ900 (manually curated from
iMM904 [29]), as the maximum gene coverage overlap with the
experimental dataset was the main criterion. Simulation condi-
tions are provided in Text S1.
Normalized lMoMA
Normalized lMoMa was formulated as follows:
min
X
i
1
DvWTi D
DvWTi {vi D V i[N : v
WT
i =0
s:t: S:v~0
vlbi ƒviƒv
ub
i V i[N
Where N is the set of all reactions, M is the set of all intracellular
metabolites, S is the stoichiometric matrix and vi is the flux for
reaction i. WT stands for wild-type (or reference), vi
lb and vi
up are
the lower and upper bounds for the flux of reaction i.
Minimization of metabolites balance – MiMBl
Metabolite turnover is defined as the sum of all fluxes producing
(or consuming) it, multiplied by the stoichiometric coefficients:
tm~
X
i[Nm
am,ivi Vm[M,Nm5N
Nm is the subset of N producing or consuming metabolite m and
am,i is the stoichiometric coefficient of metabolite m in reaction i.
Note that am,i is always a positive number in the definition above,
irrespective of m being a substrate or a product.
Figure 4. Understanding genetic interactions by using MiMBl. a, b) The accuracy of genetic interaction predictions by FBA, lMoMA and
MiMBl was assessed by calculating the sensitivity and precision for positive (a) and negative (b) interactions. Sensitivity was calculated as the fraction
of experimentally observed interactions captured by the algorithm, while precision was estimated as the fraction of experimentally observed
interactions among the predicted interactions. c) Venn diagram showing the overlap of the correctly predicted interactions by FBA, MiMBl and
lMoMA. d, e) Distribution of the graph theoretical distances, within the yeast metabolic network, between the interacting genes captured by FBA (d)
and MiMBl (e). As MiMBl also captured the majority of FBA predicted interactions, only exclusive MiMBl interactions are shown in (e). f) The S.
cerevisiae genetic interactions network correctly predicted by MiMBl and/or FBA (FBA – dashed line, MiMBl – dotted line, both – full line). Positive and
negative interactions are distinguished by color (orange and blue, respectively) and the opacity of the edges is inversely proportional to the network
distance between the corresponding genes. Gray-filled nodes represent genes that display both positive and negative interactions. Gray areas
enclose isoenzymes where at least one of them was found to interact with other genes in the metabolic network.
doi:10.1371/journal.pcbi.1002758.g004
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MiMBl was formulated as two sequential linear programming
problems, as follows:
1st optimization:
min
X
m[M
DtWTm {tmD
s: t:
S:v~0
tm~
X
i
am,ivi Vi[Nm,Nm5N :Sm,i=0
am,i:DSm,i D Vi[N,m[M
vlbi ƒviƒv
ub
i Vi[N
vi§0 Vi[N
2nd optimization:
min
X
i
1
DvWTi D
DvWTi {vi D Vi[N : v
WT
i =0
s: t S:v~0
vlbi ƒviƒv
ub
i Vi[NX
m[M
DtWTm {tmD~min
X
m[M
DtWTm {tmD
We note that MiMBl integrates reaction-to-metabolite turnover
mapping into the model formulation in terms of defining biological
objective functions and thereby making metabolite-usage a
determinant for the prediction of metabolic phenotypes. This
formulation is thus different from metabolite-centric approaches
that have been proposed for interpreting simulation results [30–
32].
Alternative stoichiometry representations
Alternative stoichiometry representations were obtained by
multiplying a given reaction (or a set of reactions) by a scalar h (or
a set of scalars). Consider reaction r : aY ,rYzaX ,rX?aZ,rZ, for
which an equivalent representation is given by:
haY ,rYzhaX ,rX?haZ,rZ Vhw0
where Y, X and Z represent the metabolites participating in
reaction r and aYr, aXr, aZr represent the corresponding stoichio-
metric coefficients. Note that when the stoichiometry of reaction r
is scaled by h, the corresponding flux value will be scaled by 1/h
for the same optimal solution. For illustrating the impact of linear
scaling of the reactions stoichiometry on the internal flux
distribution, the reaction RPI1 of iFF708 model was divided by
the scalar h. For illustrating the impact of using alternative
stoichiometry representations on the design of metabolic engi-
neering strategies, two biochemically equivalent stoichiometric
matrices were used: i) the as-published matrix from the yeast
model (S0) and ii) an equivalent matrix (S1) where the stoichio-
metric coefficients of the reactions SERxtO, PDC6, FUR1,
GAP1_21, PNP1_1, and CYSxtO were divided by 100, 100, 0.1,
0.01, 100 and 0.1, respectively. A third equivalent matrix (S2) was
generated by dividing the coefficients of a single reaction (PGK1)
by 0.1. The results of the comparison between S0 and S2 are
presented in Fig. S6.
Impact of scaling stoichiometry on the optimal solution –
Analytical evidence
The impact of scaling the constraints of a given linear
programming problem depends on whether such changes
guarantee the optimality conditions after scaling. Consider the
problem:
min
X
i[N
civi
s:t: S:v~b
vi§0
Where ci is the cost coefficient of variable vi in the objective
function. Here, a linear combination of non-normalized fluxes is
used in the objective function, similarly to e.g. minimization of
intracellular flux and lMoMA. Assuming that B is an optimal basis
matrix for the problem, the following optimization condition is
satisfied:
cj~cj{cB
0B{1Sj
cj§0, Vj[N
where j is the index of variable v in matrix S, cj is the reduced cost
of the variable vj , cj is the objective function coefficient of vj , cB is
the vector containing the objective coefficients of basic variables
and Sj is the j
th column of matrix S [33]. Linear scaling the
problem by the matrix H will result in the following reduced cost
for each variable:
cjH~cj{cB
0 BHBð Þ{1hjjSj
Where H is a n|n positive diagonal matrix (scaling matrix) and
hjj is the scaling factor for the j
th column of matrix S. In the cases
of entries hjj=1 the corresponding columns of S are accordingly
scaled. Analogously, HB is the scaling matrix corresponding to the
basic variables.
Unless all entries of H are identical,
A h [ <z : cj{cB 0 BHBð Þ{1hjjSjƒ0 Vj[N
Therefore the optimality condition is not guaranteed.
Corollary 1: When all (diagonal) entries of H are identical
(uniform scaling matrix), and therefore equal to hjj , the optimality
condition is simplified to
cjH~cj{cB
0HB{1B{1hjjSj
where HB
{1~
1
hjj
I
cjH~cj{cB
0B{1Sj~cj
cj§0[cjH§0
The same optimality condition can thus be guaranteed only when
the matrix S is uniformly scaled. Note that due to the nature of the
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biological problem, the genuine representation of S might not be
known, thereby H cannot be guaranteed to be a uniform scaling
matrix. More importantly, for metabolic modeling purposes
(where flux units and ranges are problem dependent), it is
nevertheless undesirable that the solution is sensitive to non-
uniform scaling and thus context dependent.
Corollary 2: For any positive diagonal scaling matrix H, the
same optimality condition is still guaranteed if the cost coefficients
vector Cð Þ is also scaled by H. However, the choice of the
appropriate H for formulating a biologically meaningful problem
will require existence of a unique representation of S for any given
network, which is not possible due to subjective nature of
stoichiometry representation.
Now consider the following MiMBl-like formulated problem:
min
X
m[M
cmtm
s:t: S:v~b
tm§0
Where, cm is cost coefficient of variable tm in the objective
function. The new problem biologically corresponds to the
previous one, after mapping the flux space into metabolite space.
We term it as a MiMBl-like problem formulation.
As tm~
X
i[Nm
am,ivi Vm[M,Nm5N
Recall that am,i is the stoichiometric coefficient of metabolite m in
reaction i. The objective function can be re-written as function of
vi:
min
X
m[M
cm
X
i[Nm
am,ivi
 ! !
Vm[M,Nm5N
~
min
X
i[N
X
m[M
cmam,ið Þ:vi
 !
Therefore, the objective function coefficient of each vi is a function
of the stoichiometric coefficients am,i: ci~
P
m[M
cmam,i:
Similarly to the previous problem, the following optimality
condition is satisfied, so v is an optimal solution.
cj~cj{cB
0B{1Sj
cj§0 Vj[N
Scaling the optimality condition will result in:
cjH~cjhjj{cB
0HB BHBð Þ{1hjjSj
~cjhjj{cB
0HBHB{1B{1hjjSj
~hjj : cj{cB
0B{1Sj
 
cj{cB
0B{1Sj
 
§0 and hjjw0
cjH§0
Unlike the previous situation (sum of fluxes in the objective
function), using a MiMBl-like problem formulation guarantees
that the optimality condition is always satisfied, independently of
the stoichiometry representation.
Sensitivity analysis
The sensitivity of MiMBl and lMoMA towards the use of FBA
alternative optima for wild-type flux distribution was evaluated by
performing single gene deletion simulations while using 500
different flux distributions corresponding to alternative optima of
the same FBA solution. FBA alternative optimal solutions were
obtained following a Mixed Integer Linear Programming (MILP)
routine similar to the one suggested by Lee et al. [34]. Flux
variability analysis of the flux distributions obtained with MiMBl
and lMoMA were performed according to the procedure
suggested by Mahadevan et al. [26]: maximizing and minimizing
internal fluxes after constraining the objective function to its
optimal value. In case of MiMBl, this implies adding an additional
constraint of the minimum Manhattan distance between the wild-
type and the mutant metabolite turnovers. In case of lMoMA, the
Manhattan distance between the mutant and the wild-type fluxes
will have an upper bound. Growth is uniquely predicted if
vminGrowth~v
max
Growth. Cases of v
min
Growth~v
max
Growth = 0 were also treated as
vminGrowth

vmaxGrowth = 1, solely for the purpose of visualization (Fig. 3d).
Supporting Information
Figure S1 Comparing the variability of predicted internal fluxes
of glycolysis and pentose phosphate pathway between the models
iFF708 and iAZ900. Metabolites uptake and production rates, as
well as growth from [28] were used to constraint both models and
a flux variability analysis as suggested by [26] was performed for
the represented fluxes from a) glycolysis and pentose b) phosphate
pathway. Flux names are represented as in iFF708 [21].
(TIF)
Figure S2 Profiles obtained for the objective function value
(minimization of overall intracellular flux) using alternative
stoichiometry representations of S. cerevisiae genome-scale model
iFF708 [21]. This analysis is complementary to and based on the
same simulation constraints as used for Fig. 1 in the main text. As
the contribution of each flux to the objective function changes
based on the corresponding stoichiometry representation, different
situations could be described, leading either to the same (a, b) or
distinct (c, d) optimal solutions. To illustrate these different
situations, four reactions within the model were linearly scaled one
at a time by multiplying by a scalar h as described in Methods. a)
Linear scaling of the reaction FBP1. As FBP1 carries no flux under
the simulated conditions, the scaling of this reaction does not affect
the objective function value. b) Linear scaling of the reaction
RPE1. For the range of h tested, the objective function value
perfectly correlated with the scaling factor of the reaction RPE1,
which indicates that all obtained solutions are in fact the same
optimal solution (or alternative optimal solutions, depending on
the model complexity). This profile means that there is no pathway
alternative to RPE1 that can become part of the optimal solution.
c) Linear scaling of the reaction RPI1. For the range of tested h, at
least two slopes are observed when correlating the objective
function value with 1/h, indicating that at least two different
optimal solutions were found for the same problem. d) Linear
scaling of the reaction NDI1. Similarly to that of RPI1, scaling of
NDI1 leads to different optimal solutions. However, in this case,
the objective function value stabilizes after a given h, which means
that this flux no longer influences the optimization. Such profile
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suggests that the optimal solution found after the given value of h
does no longer involve NID1, but an alternative pathway, which
became preferred for minimizing the objective function.
(TIF)
Figure S3 A toy-model illustrating how, and why, alternative
stoichiometry representations influence simulation of minimization
of metabolic adjustment by using normalized lMoMA –
normlMoMA. a) Toy-model: R1 to R7 and A to D represent
reactions and metabolites, respectively. In the wild-type, or
reference, flux goes from A to D via R5. R6 and R2–R3–R4 are
two alternative pathways for flux re-distribution after deletion of
R5. b) Flux through reactions R2 (full symbols) and R6 (open
symbols) obtained after simulation with normlMoMA by using
alternative representations of reaction R6 (given by different hR6,
Methods). c) Formulation of normlMoMA objective function
(Methods). d) Optimal objective function value (distance)
obtained for minimization of metabolic adjustment as function
of hR6.
(TIF)
Figure S4 Impact of stoichiometry representation on the design
of metabolic engineering strategies depending on the nature of the
objective function formulation – MiMBL versus lMoMA. Shown is
the comparison of predicted succinate and vanillin-glucoside yields
for triple gene knockout mutants obtained with two alternative
stoichiometric matrices (S0 and S1, Methods). Number of mutants
diverging in their lMoMA-predicted a) succinate and b) vanillin-
glucoside yields for the two alternative representations of
stoichiometry. The x-axis represents the percentage of deviation
of product formation by the mutants relative to S0. c) Comparison
of ranks of lMoMA-predicted metabolic engineering strategies for
improving succinate and vanillin-glucoside production, obtained
by using S0 and S1. d) Comparison of ranks of MiMBL-predicted
metabolic engineering strategies for improving succinate and
vanillin-glucoside production, obtained by using S0 and S1.
(TIF)
Figure S5 Stoichiometry representation impacts the design of
metabolic engineering strategies for improving succinate produc-
tion in S. cerevisiae depending on the nature of the objective
function formulation. Shown is the comparison of predicted
succinate yield for a) single, b) double and c) triple gene knockout
mutants obtained with two alternative stoichiometric matrices (S0
and S1, Methods). The number of mutants diverging in their
lMoMA-predicted succinate yield for the two alternative repre-
sentations of stoichiometry is represented on the y-axis, while the
percentage of deviation of product formation by the mutants
relative to S0 is represented on the x-axis. d–f) Comparison of
ranks of lMoMA-predicted metabolic engineering strategies for
improving succinate production obtained by using S0 and S1 for d)
single, e) double and f) triple gene knockout mutants.
(TIF)
Figure S6 Stoichiometry representation impacts the design of
metabolic engineering strategies for improving vanillin-glucoside
production in S. cerevisiae depending on the nature of the objective
function formulation. Shown is the comparison of predicted
vanillin-glucoside yield for a) single, b) double and c) triple gene
knockout mutants obtained with two alternative stoichiometric
matrices (S0 and S1, Methods). The number of mutants diverging
in their lMoMA-predicted vanillin-glucoside yield for the two
alternative representations of stoichiometry is represented on the
y-axis, while the percentage of deviation of product formation by
the mutants relative to S0 is represented on the x-axis. d–f)
Comparison of ranks of lMoMA-predicted metabolic engineering
strategies for improving vanillin-glucoside production obtained by
using S0 and S1 for d) single, e) double and f) triple gene knockout
mutants.
(TIF)
Figure S7 Stoichiometry representation impacts the design of
metabolic engineering strategies for improving succinate and
vanillin-glucoside yields in S. cerevisiae depending on the nature of
the objective function formulation. a–f) Number of mutants
diverging in their lMoMA-predicted a–c) succinate and d–f)
vanillin-glucoside yields for two alternative representations of
stoichiometry, S0 and S2 (Methods). Results for a,d) single, b,e)
double and c,f) triple gene knockout mutants are presented. g–l)
Comparison of ranks of lMoMA-predicted metabolic engineering
strategies for improving g–i) succinate and j–l) vanillin-glucoside
production obtained by using S0 and S2. Results for g,j) single, h,k)
double and i,l) triple gene knockout mutants are presented.
(TIF)
Figure S8 Alternative optima and sensitivity to reference flux
distribution. a) The left side of the panel illustrates the variability
due to possible uncertainty in the reference flux distribution, for
example, as obtained by FBA simulations. The right hand side of
the panel illustrates variability in the simulation result owing to the
possibility of alternative optimal solutions of the MiMBL linear
programming problem. Deletion of Gene 1 illustrates a case where
a unique optimal solution is found, while deletion of Gene 2
depicts a case of alternative optima. b) Flux variability analysis to
assess the existence of the alternative optimal solutions for a given
reference flux distribution (Methods). Shown are the flux
variability ranges of alanine transport and flux through phospho-
glucomutase (PGM1) after deletion of YBL045C and YOR128C,
respectively. PGM1 represents a case where the 2nd optimization
step of MiMBL contributes to reducing of flux variability. The
corresponding results for lMoMA are presented in Fig. S9. c) Flux
variability analysis for growth flux following single/double gene
deletions. MiMBL yielded unique growth prediction for single and
double gene deletion mutants. Only double gene deletions relevant
for the genetic interactions case study (main text) were simulated.
(TIF)
Figure S9 Alternative optima and sensitivity to reference flux
distribution: lMoMA. a) Sensitivity of MiMBL towards the use of
different reference flux distributions (Methods). Shown are
histograms of the simulated growth (vGrowth/v
WT
Growth) of the
mutants lacking YLR377C or YGL148W obtained with MiMBL
across 500 simulations using alternatively optimal FBA solutions.
Gray arrows mark the minimum and the maximum ratio. b) Flux
variability analysis to assess alternative optimal solutions for a
given reference flux distribution (Methods). Shown are the flux
variability ranges of alanine transport and flux through phospho-
glucomutase (PGM1) after deletion of YBL045C and YOR128C,
respectively. PGM1 represents a case where the 2nd optimization
step of MiMBL contributes to reducing of flux variability.
(TIF)
Figure S10 ROC (partial receiver operating characteristic)
curves obtained for predicting genetic interactions with MoMA.
The ROC curves for the remaining algorithms were kept for
reference. Sensitivity reflects the fraction of experimentally
validated interactions captured by the algorithm while precision
is experimentally validated interactions among all predicted
interactions. a) Positive interactions. b) Negative interactions.
(TIF)
Figure S11 Sensitivity and precision for predicted genetic
interactions versus epistasis score cutoff for FBA and MiMBL.
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The top plots present the sensitivity for positive (a) and negative (b)
interactions for FBA and MiMBL. The epistasis score cutoff of
|0.13| is represented by a dashed line. The bottom plots present
the precision for positive (c) and negative (d) interactions for FBA
and MiMBL. The epistasis score cutoff of |0.13| is represented by
a dashed line.
(TIF)
Table S1 Number of lMoMA-predicted lethal gene/reaction
knockouts in S. cerevisiae that differ between alternative represen-
tations of stoichiometry (S1 and S2), relative to S0.
(DOCX)
Table S2 lMoMA-predicted epistatic interactions within S.
cerevisiae genome-scale metabolic model.
(DOCX)
Table S3 MiMBL-predicted epistatic interactions within S.
cerevisiae genome-scale metabolic model.
(DOCX)
Table S4 All significant genetic interactions among non-essential
genes from Szappanos et al. involving genes contained in iAZ900
model included in the study.
(XLSX)
Text S1 Supplementary methods. i) Yeast genome-scale meta-
bolic models and simulation conditions; ii) Flux Balance Analysis;
iii) Minimization of overall intracellular flux; iv) Minimization of
metabolic adjustment – lMoMA; v) Genetic interactions – epistasis
score; vi) Metabolic network distance.
(DOCX)
Text S2 Supplementary notes. i) Toy-model; ii) normlMoMA;
iii) Impact of scaling stoichiometry on finding the optimal solution
for metabolic flux distributions using FBA-like objective functions
– Analytical evidence.
(DOCX)
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